Continued 19 Short Title: PM-4: High-Intensity Statin at Discharge PM-4: AMI: High-Intensity Statin Prescribed at Discharge Measure Description: Percentage of patients age 18 y, hospitalized with AMI, who were prescribed a high-intensity statin at hospital discharge. Numerator Patients with AMI who are prescribed a high-intensity statin* at hospital discharge *High-intensity statin dose is defined in Table 5 of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults14 Denominator All patients with AMI Denominator Exclusions Patients age <18 y Patients who leave against medical advice Patients who die during hospitalization Patients who are discharged to hospice or who are on comfort care measures only Patients who are transferred to another acute care hospital Denominator Exceptions Documentation of a medical reason for not prescribing a high-intensity statin (eg, allergy, intolerance or contraindications to high-intensity statin(s), risk of interaction between drugs, or other medical reasons) Documentation of prescription of a moderate-intensity statin for patients >75 y of age Documentation of a patient reason for not prescribing a statin (eg, patient refusal) Patient currently enrolled in a clinical trial related to lipid-lowering therapy Measurement Period Encounter Sources of Data Medical record or other database (eg, administrative, clinical, registry) Attribution Measure reportable at the facility or provider level Care Setting Inpatient Rationale Patients with an MI are at high risk for recurrent cardiovascular events. Statins inhibit the HMG-CoA reductase enzyme, the rate-limiting step in cholesterol biosynthesis, and are powerful drugs for lowering LDL-C, with reductions 50% observed with the high-intensity statin regimens. 